CDKN3 and neoplasm: Furthermore, upregulation of has-miR-181d-5p or silencing/inhibiting CDKN3 demonstrated inhibition of cellular proliferation, increased apoptosis, inhibition of cellular migration/invasion, repression of the Akt signaling pathway, and inhibiting tumor growth in mice.[51]